ロング
ADTX Breakout Stock Alert Update

BREAKOUT STOCK ALERT UPDATE
ADTX - ADiTx Therapeutics, Inc. - Common Stock
Initial Alert Price: $2.1
Price High: $6.73
% Gains/Losses: 220.48%
(+201% More Than Expected)
Potential Stop Loss: $6.3935
ADTX hit $6.73 providing a 180.42% Return on Investment from our initial trade alert on December 22nd, 2020 due to the release date being set for the AditxtScore Platform Immune Monitoring Platform on Feb. 1st, 2020. The initial application of the platform will be AditxtScore for Covid-19, which has been designed to provide a more complete assessment of an individual's infection and immunity status with respect to the SARS-CoV-2 virus. We're currently seeing some healthy pullback but expect this to continue to run as the stock is showing signs of reversing on the lower timeframes as of this message. Keep a close on eye on this moving forward and look forward for our Exit Strategy Alert if we see one fit for this trade at this time. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
Initial Alert Price: $2.1
Price High: $6.73
% Gains/Losses: 220.48%
(+201% More Than Expected)
Potential Stop Loss: $6.3935
ADTX hit $6.73 providing a 180.42% Return on Investment from our initial trade alert on December 22nd, 2020 due to the release date being set for the AditxtScore Platform Immune Monitoring Platform on Feb. 1st, 2020. The initial application of the platform will be AditxtScore for Covid-19, which has been designed to provide a more complete assessment of an individual's infection and immunity status with respect to the SARS-CoV-2 virus. We're currently seeing some healthy pullback but expect this to continue to run as the stock is showing signs of reversing on the lower timeframes as of this message. Keep a close on eye on this moving forward and look forward for our Exit Strategy Alert if we see one fit for this trade at this time. #Breakout #Stocks #Trading #Investing #Alerts #StockMarket #Daily #News #Today
関連の投稿
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。
免責事項
これらの情報および投稿は、TradingViewが提供または承認する金融、投資、取引、またはその他の種類の助言もしくは推奨であることを意図したものではなく、またこれらに該当するものでもありません。詳細は利用規約をご覧ください。